JP2018507497A - 接続された物理装置を使用したアプリケーションのロック解除およびそれらの間のデータ転送 - Google Patents
接続された物理装置を使用したアプリケーションのロック解除およびそれらの間のデータ転送 Download PDFInfo
- Publication number
- JP2018507497A JP2018507497A JP2017555863A JP2017555863A JP2018507497A JP 2018507497 A JP2018507497 A JP 2018507497A JP 2017555863 A JP2017555863 A JP 2017555863A JP 2017555863 A JP2017555863 A JP 2017555863A JP 2018507497 A JP2018507497 A JP 2018507497A
- Authority
- JP
- Japan
- Prior art keywords
- medical device
- application
- device application
- computing device
- medical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000012546 transfer Methods 0.000 title description 4
- 230000006870 function Effects 0.000 claims abstract description 75
- 238000004891 communication Methods 0.000 claims abstract description 61
- 238000012545 processing Methods 0.000 claims abstract description 30
- 230000008859 change Effects 0.000 claims abstract description 20
- 230000004044 response Effects 0.000 claims abstract description 20
- 239000003814 drug Substances 0.000 claims description 69
- 229940079593 drug Drugs 0.000 claims description 65
- 238000000034 method Methods 0.000 claims description 41
- 238000012544 monitoring process Methods 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 5
- 238000001802 infusion Methods 0.000 claims description 4
- 230000004962 physiological condition Effects 0.000 claims description 3
- 238000003825 pressing Methods 0.000 claims description 3
- 239000002775 capsule Substances 0.000 description 36
- 238000003860 storage Methods 0.000 description 20
- 230000015654 memory Effects 0.000 description 19
- 238000005516 engineering process Methods 0.000 description 8
- 239000006199 nebulizer Substances 0.000 description 8
- 230000003287 optical effect Effects 0.000 description 7
- 239000002552 dosage form Substances 0.000 description 6
- 238000012377 drug delivery Methods 0.000 description 6
- 230000009471 action Effects 0.000 description 5
- 238000013500 data storage Methods 0.000 description 5
- 238000013459 approach Methods 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 238000002483 medication Methods 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 206010013710 Drug interaction Diseases 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 2
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 238000001994 activation Methods 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- NDAUXUAQIAJITI-UHFFFAOYSA-N albuterol Chemical compound CC(C)(C)NCC(O)C1=CC=C(O)C(CO)=C1 NDAUXUAQIAJITI-UHFFFAOYSA-N 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 229940124630 bronchodilator Drugs 0.000 description 2
- 239000000168 bronchodilator agent Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000012790 confirmation Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000005414 inactive ingredient Substances 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 239000003149 muscarinic antagonist Substances 0.000 description 2
- 230000000737 periodic effect Effects 0.000 description 2
- 230000035479 physiological effects, processes and functions Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 229960002052 salbutamol Drugs 0.000 description 2
- 150000003431 steroids Chemical class 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- 206010061623 Adverse drug reaction Diseases 0.000 description 1
- KUVIULQEHSCUHY-XYWKZLDCSA-N Beclometasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(Cl)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)COC(=O)CC)(OC(=O)CC)[C@@]1(C)C[C@@H]2O KUVIULQEHSCUHY-XYWKZLDCSA-N 0.000 description 1
- 102100039705 Beta-2 adrenergic receptor Human genes 0.000 description 1
- VOVIALXJUBGFJZ-KWVAZRHASA-N Budesonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1C[C@H]3OC(CCC)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O VOVIALXJUBGFJZ-KWVAZRHASA-N 0.000 description 1
- LUKZNWIVRBCLON-GXOBDPJESA-N Ciclesonide Chemical compound C1([C@H]2O[C@@]3([C@H](O2)C[C@@H]2[C@@]3(C[C@H](O)[C@@H]3[C@@]4(C)C=CC(=O)C=C4CC[C@H]32)C)C(=O)COC(=O)C(C)C)CCCCC1 LUKZNWIVRBCLON-GXOBDPJESA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- VPNYRYCIDCJBOM-UHFFFAOYSA-M Glycopyrronium bromide Chemical compound [Br-].C1[N+](C)(C)CCC1OC(=O)C(O)(C=1C=CC=CC=1)C1CCCC1 VPNYRYCIDCJBOM-UHFFFAOYSA-M 0.000 description 1
- GIIZNNXWQWCKIB-UHFFFAOYSA-N Serevent Chemical compound C1=C(O)C(CO)=CC(C(O)CNCCCCCCOCCCCC=2C=CC=CC=2)=C1 GIIZNNXWQWCKIB-UHFFFAOYSA-N 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000048 adrenergic agonist Substances 0.000 description 1
- 238000012387 aerosolization Methods 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940124599 anti-inflammatory drug Drugs 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 229940090047 auto-injector Drugs 0.000 description 1
- 229950000210 beclometasone dipropionate Drugs 0.000 description 1
- 108010014499 beta-2 Adrenergic Receptors Proteins 0.000 description 1
- 102000014974 beta2-adrenergic receptor activity proteins Human genes 0.000 description 1
- 108040006828 beta2-adrenergic receptor activity proteins Proteins 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 229960004436 budesonide Drugs 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229960003728 ciclesonide Drugs 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- -1 doses Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229960000289 fluticasone propionate Drugs 0.000 description 1
- WMWTYOKRWGGJOA-CENSZEJFSA-N fluticasone propionate Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@@H](C)[C@@](C(=O)SCF)(OC(=O)CC)[C@@]2(C)C[C@@H]1O WMWTYOKRWGGJOA-CENSZEJFSA-N 0.000 description 1
- 229960002848 formoterol Drugs 0.000 description 1
- BPZSYCZIITTYBL-UHFFFAOYSA-N formoterol Chemical compound C1=CC(OC)=CC=C1CC(C)NCC(O)C1=CC=C(O)C(NC=O)=C1 BPZSYCZIITTYBL-UHFFFAOYSA-N 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229940015042 glycopyrrolate Drugs 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 229960004078 indacaterol Drugs 0.000 description 1
- QZZUEBNBZAPZLX-QFIPXVFZSA-N indacaterol Chemical compound N1C(=O)C=CC2=C1C(O)=CC=C2[C@@H](O)CNC1CC(C=C(C(=C2)CC)CC)=C2C1 QZZUEBNBZAPZLX-QFIPXVFZSA-N 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 229960001361 ipratropium bromide Drugs 0.000 description 1
- KEWHKYJURDBRMN-ZEODDXGYSA-M ipratropium bromide hydrate Chemical compound O.[Br-].O([C@H]1C[C@H]2CC[C@@H](C1)[N@@+]2(C)C(C)C)C(=O)C(CO)C1=CC=CC=C1 KEWHKYJURDBRMN-ZEODDXGYSA-M 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229960002744 mometasone furoate Drugs 0.000 description 1
- WOFMFGQZHJDGCX-ZULDAHANSA-N mometasone furoate Chemical compound O([C@]1([C@@]2(C)C[C@H](O)[C@]3(Cl)[C@@]4(C)C=CC(=O)C=C4CC[C@H]3[C@@H]2C[C@H]1C)C(=O)CCl)C(=O)C1=CC=CO1 WOFMFGQZHJDGCX-ZULDAHANSA-N 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 229960001609 oxitropium bromide Drugs 0.000 description 1
- LCELQERNWLBPSY-KHSTUMNDSA-M oxitropium bromide Chemical compound [Br-].C1([C@@H](CO)C(=O)O[C@H]2C[C@@H]3[N+]([C@H](C2)[C@@H]2[C@H]3O2)(C)CC)=CC=CC=C1 LCELQERNWLBPSY-KHSTUMNDSA-M 0.000 description 1
- 229960005489 paracetamol Drugs 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000000902 placebo Substances 0.000 description 1
- 229940068196 placebo Drugs 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 229960004017 salmeterol Drugs 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- LERNTVKEWCAPOY-DZZGSBJMSA-N tiotropium Chemical compound O([C@H]1C[C@@H]2[N+]([C@H](C1)[C@@H]1[C@H]2O1)(C)C)C(=O)C(O)(C=1SC=CC=1)C1=CC=CS1 LERNTVKEWCAPOY-DZZGSBJMSA-N 0.000 description 1
- 229940110309 tiotropium Drugs 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
- G16H20/13—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered from dispensers
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06F—ELECTRIC DIGITAL DATA PROCESSING
- G06F21/00—Security arrangements for protecting computers, components thereof, programs or data against unauthorised activity
- G06F21/30—Authentication, i.e. establishing the identity or authorisation of security principals
- G06F21/305—Authentication, i.e. establishing the identity or authorisation of security principals by remotely controlling device operation
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06F—ELECTRIC DIGITAL DATA PROCESSING
- G06F21/00—Security arrangements for protecting computers, components thereof, programs or data against unauthorised activity
- G06F21/30—Authentication, i.e. establishing the identity or authorisation of security principals
- G06F21/31—User authentication
- G06F21/34—User authentication involving the use of external additional devices, e.g. dongles or smart cards
- G06F21/35—User authentication involving the use of external additional devices, e.g. dongles or smart cards communicating wirelessly
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06F—ELECTRIC DIGITAL DATA PROCESSING
- G06F21/00—Security arrangements for protecting computers, components thereof, programs or data against unauthorised activity
- G06F21/30—Authentication, i.e. establishing the identity or authorisation of security principals
- G06F21/44—Program or device authentication
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
- G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/40—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the management of medical equipment or devices, e.g. scheduling maintenance or upgrades
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
- G16H40/67—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
- G16H40/63—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
Landscapes
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Medical Informatics (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Primary Health Care (AREA)
- Public Health (AREA)
- Theoretical Computer Science (AREA)
- Computer Security & Cryptography (AREA)
- General Business, Economics & Management (AREA)
- Business, Economics & Management (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- General Engineering & Computer Science (AREA)
- Computer Hardware Design (AREA)
- Software Systems (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Computer Networks & Wireless Communication (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Medical Treatment And Welfare Office Work (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
Abstract
Description
102 コンピューティング装置
104 ネットワーク
106 医療装置
108 スマートウォッチ
110 スマート注射器
112 心拍数モニタ
114 記憶装置
116 ワークステーション
118 サーバ
120 記憶装置
200 コンピューティング装置
210 中央処理ユニット(CPU)
212 システムバス
214 ランダムアクセスメモリ(RAM)
216 読出し専用メモリ(ROM)
218 I/Oアダプタ
220 メモリ
222 ユーザインタフェースアダプタ
224 キーボード
226 マウス
228 スピーカ
232 マイクロホン
234 通信アダプタ
236 ディスプレイアダプタ
238 ディスプレイ画面
240 タッチスクリーンインタフェース
242 ネットワーク
302 医療装置
304 コンピューティング装置
306 医療装置アプリケーション
402 メッセージ
404 リンク
502 ロック状態
504 ロック解除状態
506 ボタンの視覚的表現
508 ボタン
510 無線通信回線
602 パスワードフィールド
800 吸入器
802 本体
804 凹み
806 空気入口
808 マウスピース
810 吸入通路
812 押しボタン
Claims (20)
- 医療装置であって
前記医療装置のユーザに機能を提供し、
他の1つまたは複数の装置と無線通信チャネルを介して通信し、
医療装置アプリケーションをロック状態からロック解除状態に変化させる信号を送信するように構成された前記医療装置と、
1つまたは複数の無線通信チャネル、処理装置、および前記処理装置と統合されておりかつ/または前記処理装置によって実行可能であるロジックを備えたコンピューティング装置と
を備えたシステムであって、
前記ロジックが、前記コンピューティング装置に、
前記医療装置と通信させ、
前記医療装置アプリケーションを実行させ、
前記医療装置から前記信号を受信したことに応答して前記ロック状態から前記ロック解除状態に変化させるように構成されており、
前記医療装置アプリケーションが前記ロック状態にあるときには、前記医療装置アプリケーションの機能が無効であり、
前記医療装置アプリケーションが前記ロック解除状態にあるときには、前記医療装置に適用可能な機能が有効である、前記システム。 - 前記医療装置が単位用量吸入器である、請求項1に記載のシステム。
- 前記医療装置が前記コンピューティング装置上の前記医療装置アプリケーションと通信していないときには、前記医療装置の機能が無効である、請求項1に記載のシステム。
- 前記機能が、ユーザ吸入用のエーロゾル化された薬剤を提供すること、ユーザ注入用の液体薬剤を提供すること、および前記ユーザの生理的様態を感知することのうちの1つまたは複数を含む、請求項1に記載のシステム。
- 前記コンピューティング装置が、パーソナルコンピュータ、スマートホン、スマートウォッチ、ウェアラブル装置、タブレットコンピュータおよびラップトップコンピュータからなる群から選択される、請求項1に記載のシステム。
- 前記医療装置の前記無線通信チャネルが、前記コンピューティング装置の前記無線通信チャネルと、1つまたは複数の無線周波によって通信するように構成される、請求項1に記載のシステム。
- 前記コンピューティング装置がさらに、
前記ユーザがトリガを提供したことに応答して前記医療装置に接続しようと試み、
前記医療装置を前記医療装置アプリケーションとペアリングし、
前記医療装置の動作のためのパラメータを示す1つまたは複数のメッセージを前記医療装置に送信する
ように構成される、請求項1に記載のシステム。 - 前記医療装置がさらに、
トリガリングイベントに応答して、前記コンピューティング装置上の前記医療装置アプリケーションにメッセージを送信し、
前記コンピューティング装置上の前記医療装置アプリケーションとペアリングし、
前記医療装置の動作のためのステータスおよび/またはパラメータを示す1つまたは複数のメッセージを前記医療装置アプリケーションに送信する
ように構成される、請求項1に記載のシステム。 - 前記トリガリングイベントが、前記医療装置上のボタンを前記ユーザが押すこと、前記コンピューティング装置の無線通信範囲内に前記医療装置が入ること、および前記医療装置の利用が試みられることからなる群から選択される、請求項8に記載のシステム。
- 前記医療装置アプリケーションが前記ロック解除状態にある間、前記医療装置アプリケーションの特定の医療装置に対して適切な機能だけが有効であり、適切な機能が、前記医療装置と整合した機能であり、前記医療装置を使用しているときに可能である、請求項1に記載のシステム。
- 前記医療装置がさらに、前記医療装置アプリケーションを前記ロック状態から前記ロック解除状態に変化させる前記信号を送信した後に、予め決められた一連のメッセージを、前記コンピューティング装置上の前記医療装置アプリケーションに送信するように構成されており、
前記医療装置アプリケーションがさらに、
前記医療装置からの前記予め決められた一連のメッセージが届いていないか監視し、
予期される所定の数のメッセージが前記医療装置アプリケーションによって受信されていないと判定されたことに応答して、前記医療装置アプリケーションのコア機能を無効にするように構成されている、請求項1に記載のシステム。 - 医療装置を使用して、前記医療装置のユーザに機能を提供すること、
他の1つまたは複数の装置と無線通信チャネルを介して通信すること、および
コンピューティング装置上で実行中の医療装置アプリケーションを第1の状態から第2の状態に変化させる信号を送信すること
を含む方法。 - 前記コンピューティング装置を使用して、前記医療装置と通信すること、
前記コンピューティング装置を使用して、前記医療装置アプリケーションを実行すること、および
前記医療装置から前記信号を受信したことに応答して、前記医療装置アプリケーションを前記第1の状態から前記第2の状態に変化させること
をさらに含み、
前記医療装置アプリケーションが前記第2の状態にあるときには、前記医療装置アプリケーションの機能が無効であり、
前記医療装置アプリケーションが前記第2の状態にあるときには、前記医療装置に適用可能な機能が有効である、請求項12に記載の方法。 - 前記医療装置が単位用量吸入器である、請求項12に記載の方法。
- 前記医療装置が前記コンピューティング装置上の前記医療装置アプリケーションと通信していないときには、前記医療装置の機能を無効にすることをさらに含む、請求項12に記載の方法。
- 前記機能が、ユーザ吸入用のエーロゾル化された薬剤を提供すること、ユーザ注入用の液体薬剤を提供すること、および前記ユーザの生理的様態を感知することのうちの1つまたは複数を含む、請求項12に記載の方法。
- 前記コンピューティング装置を使用して、前記ユーザがトリガを提供したことに応答して前記医療装置に接続しようと試みること、
前記医療装置を、前記コンピューティング装置上の前記医療装置アプリケーションとペアリングすること、および
前記医療装置の動作のためのパラメータを示す1つまたは複数のメッセージを前記コンピューティング装置から前記医療装置に送信すること
をさらに含む、請求項12に記載の方法。 - トリガリングイベントに応答して、前記医療装置から前記コンピューティング装置上の前記医療装置アプリケーションにメッセージを送信すること、
前記医療装置を、前記コンピューティング装置上の前記医療装置アプリケーションとペアリングすること、
前記医療装置の動作のためのステータスおよび/またはパラメータを示す1つまたは複数のメッセージを、前記医療装置から前記医療装置アプリケーションに送信すること
をさらに含み、
前記トリガリングイベントが、前記医療装置上のボタンを前記ユーザが押すこと、前記コンピューティング装置の無線通信範囲内に前記医療装置が入ること、および前記医療装置の利用が試みられることからなる群から選択された、請求項12に記載の方法。 - 前記医療装置アプリケーションが前記ロック解除状態にある間、前記医療装置アプリケーションの特定の医療装置に対して適切な機能だけが有効であり、適切な機能が、前記医療装置と整合した機能であり、前記医療装置を使用しているときに可能である、請求項12に記載の方法。
- 前記医療装置アプリケーションを前記第1の状態から前記第2の状態に変化させる前記信号を送信した後に、予め決められた一連のメッセージを、前記医療装置から前記コンピューティング装置上の前記医療装置アプリケーションに送信すること、
前記コンピューティング装置上の前記医療装置アプリケーションを使用して、前記医療装置からの前記予め決められた一連のメッセージが届いていないか監視すること、および
所定の数のメッセージが前記医療装置アプリケーションによって受信されていないと判定されたことに応答して、前記医療装置アプリケーションのコア機能を無効にすること
をさらに含む、請求項12に記載の方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562105306P | 2015-01-20 | 2015-01-20 | |
US62/105,306 | 2015-01-20 | ||
PCT/IB2016/050242 WO2016116853A1 (en) | 2015-01-20 | 2016-01-19 | Application unlock using a connected physical device and transfer of data therebetween |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2018507497A true JP2018507497A (ja) | 2018-03-15 |
JP7040943B2 JP7040943B2 (ja) | 2022-03-23 |
Family
ID=55300732
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2017555863A Active JP7040943B2 (ja) | 2015-01-20 | 2016-01-19 | 接続された物理装置を使用したアプリケーションのロック解除およびそれらの間のデータ転送 |
Country Status (8)
Country | Link |
---|---|
US (2) | US11094409B2 (ja) |
EP (2) | EP3248123A1 (ja) |
JP (1) | JP7040943B2 (ja) |
KR (1) | KR102504798B1 (ja) |
CN (1) | CN107111687A (ja) |
AU (3) | AU2016209930A1 (ja) |
CA (1) | CA2973817A1 (ja) |
WO (1) | WO2016116853A1 (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2022541872A (ja) * | 2019-05-31 | 2022-09-28 | セロン ファーマ エス.アー. | 医薬組成物の電子的に監督された非経口投与のための吸入器 |
WO2022249443A1 (ja) | 2021-05-28 | 2022-12-01 | 日本たばこ産業株式会社 | 情報処理方法、情報処理端末、及び情報処理システム |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2821811T3 (es) | 2012-06-25 | 2021-04-27 | Gecko Health Innovations Inc | Dispositivos, sistemas y métodos para la monitorización del cumplimiento terapéutico e interacción del paciente |
KR102402909B1 (ko) | 2013-08-28 | 2022-05-27 | 게코 헬스 이노베이션즈, 인크. | 처방 준수 모니터링을 위한 디바이스, 시스템, 및 방법과 소모품 디스펜서의 사용을 모니터링하기 위한 디바이스, 시스템, 및 방법 |
TW201620569A (zh) | 2014-08-28 | 2016-06-16 | 微劑量醫療公司 | 用於吸入器之順從性監控模組 |
BR112017003865A2 (pt) | 2014-08-28 | 2018-06-26 | Microdose Therapeutx, Inc | inalador com módulo de verificação de conformidade com um limiar predeterminado. |
TW201618825A (zh) | 2014-08-28 | 2016-06-01 | 微劑量醫療公司 | 具有小型壓力感測器啟動的浪潮式乾粉吸入器 |
GB201420039D0 (en) | 2014-11-11 | 2014-12-24 | Teva Uk Ltd | System for training a user in administering a medicament |
US10058661B2 (en) | 2014-12-04 | 2018-08-28 | Norton (Waterford) Limited | Inhalation monitoring system and method |
US10230699B2 (en) | 2015-07-06 | 2019-03-12 | Pcms Holdings, Inc. | Privacy-protecting system and method for wireless medical devices |
CA3003142A1 (en) * | 2015-10-30 | 2017-05-04 | Children's Hospital And Clinics Of Minnesota | Treatment regimen compliance modification system |
US10969748B1 (en) | 2015-12-28 | 2021-04-06 | Disney Enterprises, Inc. | Systems and methods for using a vehicle as a motion base for a simulated experience |
US11524242B2 (en) | 2016-01-20 | 2022-12-13 | Disney Enterprises, Inc. | Systems and methods for providing customized instances of a game within a virtual space |
AU2017359597B2 (en) | 2016-11-18 | 2023-04-06 | Norton (Waterford) Limited | Inhaler |
AU2017361878B2 (en) | 2016-11-18 | 2022-08-11 | Norton (Waterford) Limited | Drug delivery device with electronics |
US11116899B2 (en) | 2017-12-12 | 2021-09-14 | Bigfoot Biomedical, Inc. | User interface for diabetes management systems and devices |
EP3724891B1 (en) | 2017-12-12 | 2024-08-21 | Bigfoot Biomedical, Inc. | Medicine injection and disease management systems, devices, and methods |
US10987464B2 (en) | 2017-12-12 | 2021-04-27 | Bigfoot Biomedical, Inc. | Pen cap for insulin injection pens and associated methods and systems |
US11083852B2 (en) | 2017-12-12 | 2021-08-10 | Bigfoot Biomedical, Inc. | Insulin injection assistance systems, methods, and devices |
US11077243B2 (en) | 2017-12-12 | 2021-08-03 | Bigfoot Biomedical, Inc. | Devices, systems, and methods for estimating active medication from injections |
US11464459B2 (en) | 2017-12-12 | 2022-10-11 | Bigfoot Biomedical, Inc. | User interface for diabetes management systems including flash glucose monitor |
US10970560B2 (en) | 2018-01-12 | 2021-04-06 | Disney Enterprises, Inc. | Systems and methods to trigger presentation of in-vehicle content |
US11856406B2 (en) * | 2018-01-29 | 2023-12-26 | Koninklijke Philips N.V. | Securing headless devices from malicious (re-)configuration |
TWI719288B (zh) * | 2018-03-09 | 2021-02-21 | 心誠鎂行動醫電股份有限公司 | 具有認證機制的霧化方法 |
TWI719287B (zh) * | 2018-03-09 | 2021-02-21 | 心誠鎂行動醫電股份有限公司 | 具有雙認證機制的霧化系統 |
KR102188052B1 (ko) * | 2018-11-15 | 2020-12-07 | 오스템임플란트 주식회사 | 정보 잠금 방법 및 이를 수행하는 치과용 업무 통합관리 장치 |
US11419995B2 (en) | 2019-04-30 | 2022-08-23 | Norton (Waterford) Limited | Inhaler system |
JP2022530963A (ja) | 2019-04-30 | 2022-07-05 | ノートン (ウォーターフォード) リミテッド | 吸入器システム |
EP3739591B1 (en) | 2019-05-17 | 2022-04-20 | Norton (Waterford) Limited | Drug delivery device with electronics |
JP7349176B2 (ja) * | 2019-08-16 | 2023-09-22 | 株式会社Cureapp | 治療用アプリケーションの機能を制限するためのシステム、装置、方法及びプログラム |
US11076276B1 (en) * | 2020-03-13 | 2021-07-27 | Disney Enterprises, Inc. | Systems and methods to provide wireless communication between computing platforms and articles |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006524069A (ja) * | 2003-04-23 | 2006-10-26 | バソジェン アイルランド リミテッド | 放出装置 |
JP2007307359A (ja) * | 2006-03-31 | 2007-11-29 | Lifescan Inc | 薬物送達システム及び方法 |
US20080312584A1 (en) * | 2007-06-15 | 2008-12-18 | Animas Corporation | Systems and methods to pair a medical device and a remote controller for such medical device |
US20110006876A1 (en) * | 2009-07-09 | 2011-01-13 | Medtronic Minimed, Inc. | Coordination of control commands in a medical device system having at least one therapy delivery device and at least one wireless controller device |
JP2011092418A (ja) * | 2009-10-29 | 2011-05-12 | Sharp Corp | 喘息治療支援システム |
Family Cites Families (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9913083D0 (en) | 1999-06-04 | 1999-08-04 | Novartis Ag | Organic compounds |
US6602191B2 (en) | 1999-12-17 | 2003-08-05 | Q-Tec Systems Llp | Method and apparatus for health and disease management combining patient data monitoring with wireless internet connectivity |
GB0015876D0 (en) | 2000-06-28 | 2000-08-23 | Novartis Ag | Organic compounds |
US20030086338A1 (en) | 2001-11-08 | 2003-05-08 | Sastry Srikonda V. | Wireless web based drug compliance system |
US7120488B2 (en) | 2002-05-07 | 2006-10-10 | Medtronic Physio-Control Manufacturing Corp. | Therapy-delivering portable medical device capable of triggering and communicating with an alarm system |
GB0217198D0 (en) * | 2002-07-25 | 2002-09-04 | Glaxo Group Ltd | Medicament dispenser |
AR040962A1 (es) | 2002-08-09 | 2005-04-27 | Novartis Ag | Compuestos derivados de tiazol 1,3-2-ona, composicion farmaceutica y proceso de preparacion del compuesto |
US20050097248A1 (en) | 2003-10-29 | 2005-05-05 | Kelley Brian H. | System and method for establishing a communication between a peripheral device and a wireless device |
GB0410712D0 (en) | 2004-05-13 | 2004-06-16 | Novartis Ag | Organic compounds |
JP5009790B2 (ja) | 2004-06-15 | 2012-08-22 | コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ | 患者の生理信号を取得するためのセンサ |
JP2008538708A (ja) | 2005-04-11 | 2008-11-06 | エフ.ホフマン−ラ ロシュ アーゲー | ウェブ対応携帯型医療デバイス |
US7733224B2 (en) | 2006-06-30 | 2010-06-08 | Bao Tran | Mesh network personal emergency response appliance |
DE102005062579A1 (de) | 2005-12-27 | 2007-07-05 | Siemens Ag | Vorrichtung zum drahtlosen Datenaustausch sowie Verfahren zum Aufbau einer drahtlosen Verbindung zwischen einer insbesondere medizinischen Sensoreinheit und einer Rechnereinheit |
US20070166662A1 (en) | 2006-01-17 | 2007-07-19 | Kevin Lint | Hard-wired and wireless system with footswitch for operating a dental or medical treatment apparatus |
US8770482B2 (en) | 2006-04-26 | 2014-07-08 | Roche Diagnostics Operations, Inc. | Apparatus and method to administer and manage an intelligent base unit for a handheld medical device |
US9135810B2 (en) * | 2006-11-28 | 2015-09-15 | Medallion Therapeutics, Inc. | Method, apparatus and system for assigning remote control device to ambulatory medical device |
EP2102775B1 (en) | 2006-12-06 | 2019-07-03 | Medtronic, Inc. | Intelligent discovery of medical devices by a programming system |
US9550031B2 (en) | 2008-02-01 | 2017-01-24 | Reciprocal Labs Corporation | Device and method to monitor, track, map, and analyze usage of metered-dose inhalers in real-time |
WO2010035202A1 (en) | 2008-09-26 | 2010-04-01 | Koninklijke Philips Electronics N.V. | Authenticating a device and a user |
US20100095251A1 (en) | 2008-10-15 | 2010-04-15 | Sony Ericsson Mobile Communications Ab | Linkage between motion sensing and position applications in a portable communication device |
US20120081207A1 (en) | 2010-09-30 | 2012-04-05 | Apple Inc. | Application launching in conjunction with an accessory |
US9015487B2 (en) | 2009-03-31 | 2015-04-21 | Qualcomm Incorporated | Apparatus and method for virtual pairing using an existing wireless connection key |
US20110009725A1 (en) * | 2009-07-09 | 2011-01-13 | Medtronic Minimed, Inc. | Providing contextually relevant advertisements and e-commerce features in a personal medical device system |
US8279076B2 (en) | 2009-07-14 | 2012-10-02 | Sam Johnson | Motion or opening detector |
US9167991B2 (en) | 2010-09-30 | 2015-10-27 | Fitbit, Inc. | Portable monitoring devices and methods of operating same |
US8929995B2 (en) * | 2010-10-29 | 2015-01-06 | Medtronic, Inc. | Implantable medical device telemetry in disruptive energy field |
RU2591625C2 (ru) | 2011-03-15 | 2016-07-20 | Новартис Аг | Ингалятор |
US9332544B2 (en) * | 2011-04-11 | 2016-05-03 | Lg Electronics Inc. | Channel switching method in a medical body area network |
KR101121441B1 (ko) | 2011-06-16 | 2012-03-16 | 에이큐 주식회사 | 엔에프시 통신방식의 이동통신단말기 및 그 제어방법 |
US9218455B2 (en) * | 2011-10-19 | 2015-12-22 | Cerner Innovation, Inc. | Dynamic pairing of devices with a medical application |
US9936382B2 (en) | 2011-11-21 | 2018-04-03 | Vital Connect, Inc. | Method and system for pairing a sensor device to a user |
US9186071B2 (en) | 2012-01-27 | 2015-11-17 | Qualcomm Incorporated | Unlocking a body area network |
DE102012201505B4 (de) | 2012-02-02 | 2013-08-22 | Siemens Aktiengesellschaft | Authentisierungssystem für mobile Geräte zum Datenaustausch von medizinischen Daten |
US9703931B2 (en) | 2012-06-06 | 2017-07-11 | Jennifer M. Hinkel | Method and system for authenticating and monitoring home health interactions |
US20150186615A1 (en) | 2012-07-19 | 2015-07-02 | Remind Technologies Inc. | Medication compliance |
US9549323B2 (en) | 2012-12-03 | 2017-01-17 | Samsung Electronics Co., Ltd. | Method and mobile terminal for controlling screen lock |
US20140208333A1 (en) | 2013-01-22 | 2014-07-24 | Motorola Mobility Llc | Initialize a Computing Device to Perform an Action |
US9065720B2 (en) | 2013-03-12 | 2015-06-23 | Roche Diagnostics Operations, Inc. | Medical device and external device coordination systems and methods |
CN103257873B (zh) | 2013-04-18 | 2016-07-06 | 小米科技有限责任公司 | 一种智能终端设备的控制方法和系统 |
US20140322815A1 (en) | 2013-04-26 | 2014-10-30 | Roche Diagnostics Operations, Inc. | Pairing and synchronizing a mobile phone application with a handheld glucose meter |
WO2014204511A2 (en) | 2013-06-18 | 2014-12-24 | Isonea Limited | Compliance monitoring for asthma inhalers |
WO2015097662A1 (en) * | 2013-12-23 | 2015-07-02 | Glenmark Pharmaceuticals Ltd | A dry powder inhaler |
CN103927019A (zh) | 2014-05-06 | 2014-07-16 | 北京金山安全软件有限公司 | 移动设备中应用程序的打开方法、系统及移动设备 |
US11033694B2 (en) * | 2014-09-22 | 2021-06-15 | Koninklijke Philips N.V. | Inhaler with orientation sensor |
US9854973B2 (en) * | 2014-10-25 | 2018-01-02 | ARC Devices, Ltd | Hand-held medical-data capture-device interoperation with electronic medical record systems |
-
2016
- 2016-01-19 US US15/544,349 patent/US11094409B2/en active Active
- 2016-01-19 EP EP16702984.2A patent/EP3248123A1/en not_active Withdrawn
- 2016-01-19 KR KR1020177019785A patent/KR102504798B1/ko active IP Right Grant
- 2016-01-19 EP EP19196736.3A patent/EP3703065A1/en not_active Withdrawn
- 2016-01-19 CA CA2973817A patent/CA2973817A1/en active Pending
- 2016-01-19 JP JP2017555863A patent/JP7040943B2/ja active Active
- 2016-01-19 WO PCT/IB2016/050242 patent/WO2016116853A1/en active Application Filing
- 2016-01-19 CN CN201680006237.8A patent/CN107111687A/zh active Pending
- 2016-01-19 AU AU2016209930A patent/AU2016209930A1/en not_active Abandoned
-
2019
- 2019-01-29 AU AU2019200559A patent/AU2019200559A1/en not_active Abandoned
-
2020
- 2020-10-22 AU AU2020257123A patent/AU2020257123B2/en active Active
-
2021
- 2021-08-13 US US17/401,770 patent/US20210398636A1/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006524069A (ja) * | 2003-04-23 | 2006-10-26 | バソジェン アイルランド リミテッド | 放出装置 |
JP2007307359A (ja) * | 2006-03-31 | 2007-11-29 | Lifescan Inc | 薬物送達システム及び方法 |
US20080312584A1 (en) * | 2007-06-15 | 2008-12-18 | Animas Corporation | Systems and methods to pair a medical device and a remote controller for such medical device |
US20110006876A1 (en) * | 2009-07-09 | 2011-01-13 | Medtronic Minimed, Inc. | Coordination of control commands in a medical device system having at least one therapy delivery device and at least one wireless controller device |
JP2011092418A (ja) * | 2009-10-29 | 2011-05-12 | Sharp Corp | 喘息治療支援システム |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2022541872A (ja) * | 2019-05-31 | 2022-09-28 | セロン ファーマ エス.アー. | 医薬組成物の電子的に監督された非経口投与のための吸入器 |
WO2022249443A1 (ja) | 2021-05-28 | 2022-12-01 | 日本たばこ産業株式会社 | 情報処理方法、情報処理端末、及び情報処理システム |
Also Published As
Publication number | Publication date |
---|---|
KR20170106334A (ko) | 2017-09-20 |
CA2973817A1 (en) | 2016-07-28 |
AU2016209930A1 (en) | 2017-07-13 |
CN107111687A (zh) | 2017-08-29 |
KR102504798B1 (ko) | 2023-03-02 |
WO2016116853A1 (en) | 2016-07-28 |
AU2020257123B2 (en) | 2022-08-04 |
US20180011988A1 (en) | 2018-01-11 |
AU2020257123A1 (en) | 2020-11-19 |
JP7040943B2 (ja) | 2022-03-23 |
EP3703065A1 (en) | 2020-09-02 |
US11094409B2 (en) | 2021-08-17 |
US20210398636A1 (en) | 2021-12-23 |
AU2019200559A1 (en) | 2019-02-14 |
EP3248123A1 (en) | 2017-11-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2020257123B2 (en) | Application unlock using a connected physical device and transfer of data therebetween | |
US11400242B2 (en) | Inhaler adapted to read information stored in data storage means of a container | |
US20220361758A1 (en) | Drug administration devices that communicate with external systems and/or other devices | |
AU2020309514A1 (en) | Drug delivery device with electronics and power management | |
CN114730626A (zh) | 用于建立给药方案和部件的兼容性的药物施用装置和系统 | |
EP4168077A1 (en) | Inhaler system | |
CN116583908A (zh) | 与外科集线器通信的药物施用装置 | |
AU2021291033A1 (en) | Inhaler system |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20190118 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20191016 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20191112 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20200212 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20200508 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20200623 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20201021 |
|
C60 | Trial request (containing other claim documents, opposition documents) |
Free format text: JAPANESE INTERMEDIATE CODE: C60 Effective date: 20201021 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20201030 |
|
C21 | Notice of transfer of a case for reconsideration by examiners before appeal proceedings |
Free format text: JAPANESE INTERMEDIATE CODE: C21 Effective date: 20201104 |
|
A912 | Re-examination (zenchi) completed and case transferred to appeal board |
Free format text: JAPANESE INTERMEDIATE CODE: A912 Effective date: 20201204 |
|
C211 | Notice of termination of reconsideration by examiners before appeal proceedings |
Free format text: JAPANESE INTERMEDIATE CODE: C211 Effective date: 20201208 |
|
C22 | Notice of designation (change) of administrative judge |
Free format text: JAPANESE INTERMEDIATE CODE: C22 Effective date: 20210413 |
|
C13 | Notice of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: C13 Effective date: 20210608 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20210907 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20211206 |
|
C22 | Notice of designation (change) of administrative judge |
Free format text: JAPANESE INTERMEDIATE CODE: C22 Effective date: 20220105 |
|
C23 | Notice of termination of proceedings |
Free format text: JAPANESE INTERMEDIATE CODE: C23 Effective date: 20220111 |
|
C03 | Trial/appeal decision taken |
Free format text: JAPANESE INTERMEDIATE CODE: C03 Effective date: 20220215 |
|
C30A | Notification sent |
Free format text: JAPANESE INTERMEDIATE CODE: C3012 Effective date: 20220215 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20220310 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 7040943 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |